The preliminary efficacy of KN026 (Anti-HER2 BsAb) in advanced gastric and gastroesophageal junction cancer patients with HER2 expression.Jianming Xu, Ting Xu, Jieer Ying et al.|Journal of Clinical Oncology|2021Cited by 13